MariMed Inc. (MRMD) stock
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
Earnings
MariMed's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of MariMed's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 12, 2026after the close | – | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 13, 2026after the close | $39.50M | +4.1% | -$0.01 | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 11, 2026after the close | – | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025after the close | $40.80M | +0.5% | -$0.01 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | – | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $37.96M | – | -$0.01 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 5, 2025after the close | – | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024after the close | $40.60M | – | $0.00 | $0.50 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | – | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024after the close | – | – | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 6, 2024after the close | – | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 8, 2023after the close | – | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023after the close | – | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 8, 2023after the close | – | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 1, 2023after the close | – | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022after the close | – | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 8, 2022after the close | – | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 16, 2022after the close | – | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 21, 2022after the close | – | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 18, 2021after the close | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 20, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 26, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 16, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period MariMed guided for has been reported
Guidance history
Every forecast MariMed put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 6, 2024 | Capital Expenditures | FY2024 | $11.00M | New |
| Nov 6, 2024 | Non-GAAP Adjusted EBITDA | FY2024 | -20% – -18% | New |
| Nov 6, 2024 | Revenue Growth | FY2024 | +6% – +8% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases MariMed filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
See a number that looks wrong?